VP64-p65-Rta tripartite transcriptional activation domain (VPR)
Synthetic tripartite transcriptional activation domain joining VP64, the p65 activation domain of NF-κB, and Epstein-Barr virus Rta. Fused to nuclease-null Cas9 it activates endogenous genes 22- to 320-fold more strongly than dCas9-VP64, and it was designed to overcome the modest activation of earlier dCas9 activators.
| Origin | Synthetic fusion of VP64, p65, and Rta |
|---|---|
| Domain Class | Activator |
Characteristics
Built by screening more than 20 candidate effectors as C-terminal dCas9 fusions in HEK293T cells, then extending dCas9-VP64 with p65, with Rta, and finally with both in tandem. Against dCas9-VP64, dCas9-VPR gives 22- to 320-fold higher activation of endogenous targets, though the gain varies markedly between target genes. Replacing any one of the three domains with mCherry lowers activity, and testing permutations confirmed that the VP64-p65-Rta order is optimal. VPR also raises activation over VP64 when fused to S. thermophilus dCas9, to a TALE, or to a zinc-finger protein, so it is not specific to S. pyogenes dCas9.
Applications
Activator domain of dCas9-VPR for endogenous coding and noncoding genes in human cells, and for pooled activation of several genes at once, shown for MIAT, NEUROD1, ASCL1 and RHOXF2. Raises activation 5- to 300-fold over VP64 activators in S. cerevisiae, Drosophila S2R+ cells and mouse Neuro-2A cells, and drives neuronal differentiation of human iPS cells.
Limitations
Characterized as a fusion to a DNA-binding protein rather than on its own. The three domains add to the roughly 4.1 kb of dCas9, so a dCas9-VPR cassette does not fit in a single AAV vector with a promoter and polyA signal. The fold-improvement over VP64 varies widely between target genes, so activation at a new locus is not predictable from these figures.
Mechanism
Three activation domains of different origin fused in series as VP64-p65-Rta. The combination activates more strongly than any single domain, and the order of the three is itself load-bearing.
Built into
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Chavez et al. (2015). Highly efficient Cas9-mediated transcriptional programming. Nat Methods — Chavez 2015 VPR
- 2.Mali et al. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol — Mali 2013 Cas9 Nickase
